Retaglutide is a novel GLP-1 receptor agonist currently under research for the treatment of metabolic disorders. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://berthaggmb992141.blog5star.com/39401206/retaglutide-a-promising-glp-1-receptor-agonist